A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Our team

We work every day to change how pharmaceutical companies bring their medicines to the poor. In addition to our in-house Foundation team, we are supported by formal committees of independent experts and reviewers. The strategic supervision of the Access to Medicine Foundation is in the hands of its Supervisory Board.

Experts

Hans Hogerzeil

Chair of the Expert Review Committees

Fumie Griego

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Dennis Ross-Degnan

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Yo Takatsuki

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Prashant Yadav

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Greg Frank

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Nina Grundmann

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Magdalena Kettis

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Joakim Larsson

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Marc Mendelson

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Margareth Ndomondo-Sigonda

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Katarina Nedog

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark (until September 2018)

Sarah Paulin

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Andrew Singer

Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Emily Bleimund

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Githinji Gitahi

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Kibachio Joseph Muiruri Mwangi

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Andrew Rintoul

Observer of the 2019 Expert Review Committee for the Access to Medicine Index

Kawaldip Sehmi

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Alan Staple

Member of the 2019 Expert Review Committee for the Access to Medicine Index

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |